I totally agree that they either need to tell us the trial has concluded, or if not why. The why might be interesting if the trial was restructured into a Phase 1/2 and we're now in the Phase 2 portion. That portion might have patients who suffer with psoriasis, and possibly other skin diseases, and if that were the case, we'd be ahead of the game instead of being behind it.

I think we'll know something by the 4th of July holiday. Top line data shouldn't take long to put together, a detailed presentation is a different matter. Hopefully Phase 1 data says that it's a very safe cream to use. Could you swim in it, I certainly can't say that, but if the cream can be used several times a day without any safety concerns, then there should be few limitations on how the cream should be used.

Gary